Luxury Dining Series by Marriott International Returns in 2025
SINGAPORE, May 6, 2025 /PRNewswire/ -- Following last year's tremendous success, The Luxury Group by Marriott International is proud to announce the highly anticipated return of the Luxury Dining Series. Taking place from July to September, the multi-city regional dining series in 2025 continues to invite discerning travelers and dining enthusiasts to embark on an extraordinary gastronomic journey celebrating the revival of lost flavors and culinary traditions.
Inspired by the findings from the Future of Food 2025 report, this year's theme of Forgotten Flavors celebrates the art of culinary history and will explore time-honored techniques and innovative culinary experimentation at seven handpicked hotels. The locations of the 2025 series include The St. Regis Osaka, JW Marriott Jeju Resort & Spa, JW Marriott Bengaluru Prestige Golfshire Resort & Spa, The Ritz-Carlton, Perth, The St. Regis Singapore, The St. Regis Jakarta, and the newly opened The Ritz-Carlton, Bangkok.
Renowned chefs and mixologists from across Marriott International's global portfolio will unite, pairing masters of tradition with contemporary visionaries, to resurrect lost, neglected, and overlooked ingredients. Guests can look forward to a carefully curated gastronomic experience where every plate will offer a taste of the past, reimagined for today's palate.
The full schedule of the series is as follows:
Japan - July 11-13 - The St. Regis Osaka
Korea - July 17-20 - JW Marriott Jeju Resort & Spa
India - July 31- August 3 - JW Marriott Bengaluru Prestige Golfshire Resort & Spa
Australia - August 15-17 - The Ritz-Carlton, Perth
Singapore - August 29-31 - The St. Regis Singapore
Indonesia - September 11-13 - The St. Regis Jakarta
Thailand - September 25-28 - The Ritz-Carlton, Bangkok
More details on programming will be announced soon. Please visit the website for more information - https://www.marriott.com/en-us/marriott-brands/portfolio/luxury-dining-series.mi
Video and high-resolution images can be downloaded here
About Marriott International
Marriott International, Inc. (Nasdaq: MAR) is based in Bethesda, Maryland, USA, and encompasses a portfolio of over 9,300 properties across more than 30 leading brands in 144 countries and territories. Marriott operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties all around the world. The company offers Marriott Bonvoy®, its highly awarded travel platform. For more information, please visit our website at www.marriott.com, and for the latest company news, visit www.marriottnewscenter.com. In addition, connect with us on Facebook and @MarriottIntl on X and Instagram.
About Luxury Group by Marriott International
With an unrivaled portfolio of eight dynamic luxury brands, Marriott International is creating authentic, rare, and enriching experiences sought by today's global luxurian. Spanning all corners of the world, Marriott International's Luxury Group offers a boundless network of more than 530 landmark hotels and resorts in over 70 countries and territories through The Ritz-Carlton, Ritz-Carlton Reserve, Bvlgari Hotels & Resorts, St. Regis Hotels & Resorts, EDITION, The Luxury Collection, JW Marriott, and W Hotels. From the world's most iconic destinations to the ultimate undiscovered gems, the international hospitality leader's collection of luxury brands is focused on elevating travel with highly contextualized, nuanced brand experiences that signal the future of luxury by allowing guests to indulge their passions while sparking personal growth.
Media Contact
Joanna HuangDirector, Luxury PR & CommunicationsMarriott International, Asia Pacific excluding Chinajoanna.huang@marriottluxurybrands.com
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/luxury-dining-series-by-marriott-international-returns-in-2025-302446638.html
SOURCE Marriott International
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
28 minutes ago
- Business Wire
Fal.Con 2025 Shatters Records for Growth, Attendance and Demand as CrowdStrike Leads Cybersecurity into the Agentic AI Era
AUSTIN, Texas--(BUSINESS WIRE)-- CrowdStrike (NASDAQ: CRWD) today announced record-breaking momentum for its flagship conference which has sold out faster than ever and is poised to deliver unprecedented growth across every key metric. From September 15 - 18, more than 8,000 attendees from over 65 countries and 25 industries will converge at the MGM Grand in Las Vegas. The event will host a record 110 partner sponsors and more than 3,000 leading organizations, positioning as the global stage for cybersecurity in the Agentic AI era. ' has become the premier industry conference for cybersecurity,' said Jennifer Johnson, chief marketing officer at CrowdStrike. 'We're not hosting a summit, we're leading a movement. The world's most influential leaders come to to advance cybersecurity into the AI era, build alliances, and harness the power of the Falcon platform to secure the organizations, economies and technologies shaping our future.' Now in its ninth year, will unite the world's top defenders, executives, and innovators to accelerate breakthroughs, forge industry-shaping partnerships, and set the strategic cybersecurity agenda for the year ahead. Under the 2025 theme 'Leading Cybersecurity into the Agentic AI Era,' attendees will experience visionary keynotes from CrowdStrike executives. As part of the 300+ session catalog, the program will feature 150+ customer and partner-led sessions from global leaders such as Charter Communications, Land O'Lakes, Mars Inc., Northwestern Mutual, St. Jude Children's Research Hospital, University of Michigan, Vail Resorts, and WeightWatchers. One, the conference's exclusive CxO program, will also convene 200+ leaders from the world's most innovative organizations for high-impact, closed-door discussions on the future of cybersecurity, the transformative role of AI, and strategies to outpace adversaries. 2025 will also showcase the unmatched strength of CrowdStrike's global partner ecosystem, welcoming more than 110 partner sponsors from across the cybersecurity landscape, the most in the conference's history. Premier sponsors AWS, Dell, and Intel will be joined by Diamond sponsors ExtraHop, Google Cloud, Okta, Rubrik, and Zscaler. Attendees can also register for full-day CrowdStrike University training courses to elevate their skills, sharpen their expertise, and advance their impact as defenders. The event begins on Monday, September 15, with CrowdStrike's annual Global Partner Summit, where more than 1,000 partner participants will unite to accelerate innovation, expand go-to-market opportunities, and drive joint success with the Falcon platform. Join the Action at Register to live stream the keynotes and access 80+ sessions on-demand following the event. Start planning now: Build your digital 2025 agenda here. About CrowdStrike CrowdStrike (NASDAQ: CRWD), a global cybersecurity leader, has redefined modern security with the world's most advanced cloud-native platform for protecting critical areas of enterprise risk – endpoints and cloud workloads, identity and data. Powered by the CrowdStrike Security Cloud and world-class AI, the CrowdStrike Falcon® platform leverages real-time indicators of attack, threat intelligence, evolving adversary tradecraft and enriched telemetry from across the enterprise to deliver hyper-accurate detections, automated protection and remediation, elite threat hunting and prioritized observability of vulnerabilities. Purpose-built in the cloud with a single lightweight-agent architecture, the Falcon platform delivers rapid and scalable deployment, superior protection and performance, reduced complexity and immediate time-to-value. CrowdStrike: We stop breaches. © 2025 CrowdStrike, Inc. All rights reserved. CrowdStrike and CrowdStrike Falcon are marks owned by CrowdStrike, Inc. and are registered in the United States and other countries. CrowdStrike owns other trademarks and service marks and may use the brands of third parties to identify their products and services.
Business Wire
28 minutes ago
- Business Wire
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer's Aspirina, the #1 pain relief option in Mexico 1, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. With a deep commitment to Hispanic consumers, Aspirina is poised to provide an accessible and effective solution for pain relief. Bayer's Aspirina, the #1 pain relief option in Mexico, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. Share As the Hispanic population in the U.S. continues to grow, currently representing 19 percent of the population and projected to reach 28 percent by 2060, Bayer Aspirin recognizes the importance of connecting with this vibrant community. The Aspirina pain relief option resonates deeply with cultural values and family traditions of those from Mexican and Latin American descent who have been using it as a long-standing pain relief option. 'Many Hispanic communities still face inadequate access to healthcare and consumer goods. As the fastest-growing demographic group in the U.S., the Hispanic population presents a unique opportunity for Bayer. By adding Aspirina to the U.S. portfolio, which has a strong equity in LATAM, we are placing the consumer at the center of our strategy. Data shows that 70 percent of Hispanic consumers feel a strong connection to their country of origin, making it essential for brands to honor and reflect this sentiment,' said Mohamed Atef, Global Brand Lead for Aspirin at Bayer. Many U.S. consumers of Hispanic origin grew up with Bayer's Aspirina— their parents and grandparents relied on it, instilling trust and nostalgia for the brand. Due to those deep connections, Aspirina has a 99 percent awareness rate in Mexico, with 67 percent of consumers using it regularly 2. With this inclusion in the U.S. market, we invite consumers to reconnect with a product that represents reliability, familiarity and their heritage. Bayer invented modern aspirin 125 years ago, and it's the most trusted aspirin brand for pain relief in the U.S. 3 Many pain reliever brands have come and gone over the last century, but Bayer® Aspirin continues to be one of the most trusted pain brands on the market. Aspirina is available at select Walmart and Walgreens, making it easy for families to find the pain relief they know. Join us in celebrating the launch of Aspirina in the U.S. and rediscover a brand that feels like home — a trusted companion in the journey of life. For more information on Aspirina visit About Aspirina For over 125 years, Bayer® Aspirin has been a leading aspirin brand in proven pain relief. Aspirina is a powerful pain reliever and fever reducer that contains 500 mg of the active ingredient aspirin (NSAID*). It provides fast and effective multi-symptom relief of headaches, muscle pain, toothaches, menstrual pain and minor arthritis pain for adults and children over 12, when used as directed. Aspirina is coated to make it easy to swallow and is free of caffeine. *nonsteroidal anti-inflammatory drug About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, 'Health for all, Hunger for none,' the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 1 Based on volume sales in the last 52 weeks, via source: Grupo Knoblock/CID – Centro Integrador de Datos
Business Wire
28 minutes ago
- Business Wire
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Holdings (Nasdaq: HIND), a clinical-stage healthcare holding company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, will be ringing the Nasdaq Opening Bell today in honor of its first day of trading as 'HIND.' The occasion will also mark India's 79 th Independence Day. 'The HIND journey begins today, a journey in which anyone, anywhere in the world can now participate thanks to our stock being on Nasdaq,' said Krishna Gupta, Chairman of Vyome. 'Our commitment to shareholders is simple: every decision we make will be in their best interests because we have no debt and because our board is smart and heavily aligned with shareholders.' 'Our innovation pipeline is very deep and we have access to world-class talent in both the US and India,' said Shiladitya Sengupta, Founder of Vyome and Associate Professor of Medicine at Harvard Medical School. 'Our immediate focus will be to unlock the value of our clinical stage assets that all revolve around major unmet needs in the $100 billion immuno-inflammatory market, but our vision extends well beyond that.' 'This milestone is the result of phenomenal teamwork across continents – from our scientists and clinicians to our partners and advisors and most importantly our key investors – all united by a shared vision. We are committed to cost-effective operations to create maximal value for all our shareholders going forward,' said Venkat Nelabhotla, Co-founder and CEO of Vyome. 'It is such an honor to celebrate India's Independence Day at the Nasdaq, which we believe is a first,' added Gupta. 'We believe in the special relationship between the US and India, we are a product of it, and we are confident it will be the defining partnership of the next decade – whether in Healthcare, AI, or a number of other innovation-related corridors. Jai HIND and God Bless AMERICA!' Maxim Group LLC served as financial advisor to ReShape in connection with the transactions and Fox Rothschild LLP acted as its legal counsel. Chardan served as financial advisor to Vyome for the merger and Sichenzia Ross Ference Carmel LLP acted as its legal counsel. About Vyome Vyome is building a healthcare platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome's immediate focus is leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning across the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety. To learn more, please visit Visit us on social media: Facebook X LinkedIn Forward-Looking Statements Certain statements made in this press release are 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as 'target,' 'believe,' 'expect,' 'will,' 'shall,' 'may,' 'anticipate,' 'estimate,' 'would,' 'positioned,' 'future,' 'forecast,' 'intend,' 'plan,' 'project,' 'outlook', and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples of forward-looking statements include, among others, statements made in this release regarding the merger, including the benefits of the merger, revenue opportunities, anticipated future financial and operating performance, and results, including estimates for growth. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management's current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Vyome's control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, the following: (a) the occurrence of any event, change, or other circumstances relating to the combined company; (b) failure to obtain the necessary consents and approvals; (c) the risk that the merger disrupts current plans and operations as a result of the announcement and consummation of the merger; (e) costs related to the merger; and (f) changes in applicable laws or regulations. Vyome cautions that the foregoing list of factors is not exhaustive. Vyome cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vyome does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.
